Please assess the completion status of the following clinical trial:

Trial Title: Gabapentin Versus Estrogen for the Treatment of Hot Flashes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Menopausal women between ages 35-60~2. Must experience 7-20, moderate-severe hot flashes/day or 50-140 moderate-severe hot flashes/week for greater than two months~3. Must have had a bilateral salpingo-oopherectomy for \>12 months or amenorrhea\>6 months or #4 (below)~4. Has an FSH\>30 mIU/ml~5. Must have a signed informed consent~6. Able to function independent in all activities of daily living and be capable of reliable documentation~Exclusion Criteria:~1. Any contraindication to estrogen and progesterone replacement therapy~2. History of an MI, stroke, and/or functional decline.~3. Fails to record data in the hot flash diary\>3 days during the 2 week baseline period.~4. Unable or willing to make required visits at the specified times over the course of therapy.~5. History of any malignancies or undiagnosed vaginal bleeding.~6. History of chronic liver, gallbladder, chronic renal, cardiac or endocrine diseases

- Gender: FEMALE
- Minimum Age: 35 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).